# A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity

_Oncology Research · Yang Liu, Lixue Chen, Peng Wang et al. · 2026_

Canonical: https://diginpl.com/books/paper-or-2026-089127
Last updated: 2026-10-23

## Quick facts

- **Author:** Yang Liu; Lixue Chen; Peng Wang; Xiaoli Ma; Shuaikang Pan; Dafu Yang; Tianyu Zhou; Fang Yu ([Crossref](https://doi.org/10.32604/or.2026.089127))
- **Published:** 2026 ([Crossref](https://doi.org/10.32604/or.2026.089127))
- **Publisher:** Tech Science Press ([Crossref](https://doi.org/10.32604/or.2026.089127))
- **Journal:** Oncology Research ([Crossref](https://doi.org/10.32604/or.2026.089127))
- **DOI:** 10.32604/or.2026.089127 ([Crossref](https://doi.org/10.32604/or.2026.089127))

## Questions

**Who wrote A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity?**  
A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity was written by Yang Liu, Lixue Chen, Peng Wang, Xiaoli Ma.

**When was A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity first published?**  
A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity was first published in 2026.

## Sources

- [Publisher record (DOI, via Crossref)](https://doi.org/10.32604/or.2026.089127)

## Licence and attribution

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/or.2026.089127.

## Cite this page

"A Tanshinone IIA Sulfonate Derivative Targets USP21 to Induce SCD1 Degradation, Suppressing NSCLC Metabolism and Enhancing Antitumor Immunity". DigiNepal. Last updated 23 October 2026. https://diginpl.com/books/paper-or-2026-089127. Retrieved 14 November 2026.